Table 2 Reasonable and unreasonable omissions of drugs used during the study period
Months | Not prescribed | Total no. | |||||||
|---|---|---|---|---|---|---|---|---|---|
Reasonable omissions n (%) | Unreasonable omissions n (%) | ||||||||
DAPT | STATIN | ACEI/ARB | BB | DAPT | STATIN | ACE-I/ARB | BB | ||
1 | 2 (2.4) | 0 | 1 (1.6) | 7 (8.1) | 1 (1.2) | 0 | 14 (17) | 11 (14) | 81 |
2 | 2 (3) | 0 | 6 (7.6) | 5 (6.08) | 1 (1.3) | 0 | 4 (5.2) | 10 (13) | 76 |
3 | 5 (5.6) | 0 | 9 (9.4) | 10 (10.3) | 0 | 0 | 8 (9) | 7 (7.4) | 94 |
4 | 3 (3.2) | 0 | 4 (4.5) | 10 (12.3) | 0 | 0 | 6 (7.3) | 7 (9) | 82 |
5 | 9 (9.6) | 0 | 8 (7.9) | 8 (8.8) | 0 | 0 | 6 (6.2) | 7 (7.2) | 96 |
6 | 4 (4.9) | 0 | 2 (2.4) | 4 (4.9) | 0 | 0 | 6 (7.2) | 6 (7.2) | 83 |
7 | 6 (7.6) | 0 | 5 (6.4) | 4 (5.3) | 0 | 0 | 6 (8) | 6 (8) | 76 |
8 | 9 (12.5) | 1 (1.4) | 5 (6.6) | 4 (5.1) | 0 | 0 | 5 (7) | 4 (5.4) | 74 |
9 | 10 (11.7) | 0 | 6 (7.5) | 6 (4.2) | 0 | 0 | 5 (6) | 2 (2.3) | 84 |
10 | 8 (7.9) | 0 | 6 (5.9) | 8 (7.7) | 0 | 0 | 0 | 2 (2) | 99 |
11 | 11 (11.7) | 0 | 5 (4.9) | 8 (7.8) | 0 | 0 | 0 | 0 | 98 |
12 | 0 | 4 (4) | 6 (6.1) | 2 (2) | 0 | 0 | 0 | 0 | 102 |
Significance | P < 0.000 | P < 0.000 | P < 0.000 | P < 0.000 | |||||